n(g),n(g')-dimethyl-l-arginine has been researched along with Fetal Growth Restriction in 13 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of our study was to investigate the association between homocysteine and asymmetric dimethylarginine in preeclamptic women with and without intrauterine growth restriction compared with normal healthy uncomplicated pregnancies and normotensive pregnancies complicated by idiopathic isolated intrauterine fetal growth restriction." | 7.79 | Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction. ( Laskowska, K; Laskowska, M; Oleszczuk, J, 2013) |
| "The aim of this study was to investigate maternal asymmetric dimethylarginine (ADMA) concentrations at the three trimesters of pregnancy in uncomplicated pregnancies and in women who developed preeclampsia or had small for gestational age infants (SGA) without preeclampsia." | 7.78 | Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby. ( Batakis, E; Botsis, D; Eleftheriades, M; Haliassos, A; Hassiakos, D; Rizos, D; Rizou, M, 2012) |
| " We analyzed the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and asymmetric dimethylarginine (ADMA) in 55 Turkish patients with PE without fetal growth retardation (FGR) and in 54 healthy pregnant women." | 7.76 | Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and plasma concentrations of asymmetric dimethylarginine in Turkish pre-eclamptic women without fetal growth retardation. ( Ateş, K; Ilhan, N; Kafkasli, A; Kaman, D; Turan, F, 2010) |
| "The aim of our study was to investigate the association between homocysteine and asymmetric dimethylarginine in preeclamptic women with and without intrauterine growth restriction compared with normal healthy uncomplicated pregnancies and normotensive pregnancies complicated by idiopathic isolated intrauterine fetal growth restriction." | 3.79 | Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction. ( Laskowska, K; Laskowska, M; Oleszczuk, J, 2013) |
| "The aim of this study was to investigate maternal asymmetric dimethylarginine (ADMA) concentrations at the three trimesters of pregnancy in uncomplicated pregnancies and in women who developed preeclampsia or had small for gestational age infants (SGA) without preeclampsia." | 3.78 | Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby. ( Batakis, E; Botsis, D; Eleftheriades, M; Haliassos, A; Hassiakos, D; Rizos, D; Rizou, M, 2012) |
| "02) rose with fetal growth restriction while asymmetric dimethylarginine decreased (p = 0." | 3.78 | Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. ( Begliuomini, S; Boldrini, A; Casarosa, E; Coceani, F; Fink, B; Genazzani, AR; Ghirri, P; Pisaneschi, S; Ripoli, A; Sanchez, AM; Simoncini, T; Strigini, FA, 2012) |
| " We analyzed the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and asymmetric dimethylarginine (ADMA) in 55 Turkish patients with PE without fetal growth retardation (FGR) and in 54 healthy pregnant women." | 3.76 | Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and plasma concentrations of asymmetric dimethylarginine in Turkish pre-eclamptic women without fetal growth retardation. ( Ateş, K; Ilhan, N; Kafkasli, A; Kaman, D; Turan, F, 2010) |
| "Our results allow the conclusion that impaired NO bioavailability in pregnancies complicated by severe preeclampsia and/or IUGR result not from a reduced level or activity of eNOS or from its disturbed intracellular transport, but from increased ADMA levels, an endogenous inhibitor of the enzyme eNOS." | 1.42 | The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction. ( Laskowska, K; Laskowska, M; Oleszczuk, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Selanno, JF | 1 |
| Riu, DS | 1 |
| Tessy, T | 1 |
| Chalid, MT | 1 |
| Pelupessy, NU | 1 |
| Hartono, E | 1 |
| Dai, Y | 1 |
| Li, TH | 1 |
| He, X | 1 |
| Yan, SB | 1 |
| Gao, Y | 1 |
| Chen, Y | 1 |
| Tsikas, D | 1 |
| Bollenbach, A | 1 |
| Savvidou, MD | 1 |
| Bjørke-Jenssen, A | 1 |
| Ueland, PM | 2 |
| Bjørke-Monsen, AL | 2 |
| He, Q | 1 |
| Liu, X | 1 |
| Zhong, Y | 1 |
| Xu, SS | 1 |
| Zhang, ZM | 1 |
| Tang, LL | 1 |
| Zhang, LY | 1 |
| Du, LZ | 1 |
| Bassareo, PP | 1 |
| Fanos, V | 1 |
| Puddu, M | 1 |
| Flore, G | 1 |
| Mercuro, G | 1 |
| Laskowska, M | 3 |
| Laskowska, K | 3 |
| Oleszczuk, J | 3 |
| Vollsæter, M | 1 |
| Markestad, T | 1 |
| Øymar, K | 1 |
| Halvorsen, T | 1 |
| Turan, F | 1 |
| Ilhan, N | 1 |
| Kaman, D | 1 |
| Ateş, K | 1 |
| Kafkasli, A | 1 |
| Leszczyńska-Gorzelak, B | 1 |
| Rizos, D | 1 |
| Eleftheriades, M | 1 |
| Batakis, E | 1 |
| Rizou, M | 1 |
| Haliassos, A | 1 |
| Hassiakos, D | 1 |
| Botsis, D | 1 |
| Pisaneschi, S | 1 |
| Strigini, FA | 1 |
| Sanchez, AM | 1 |
| Begliuomini, S | 1 |
| Casarosa, E | 1 |
| Ripoli, A | 1 |
| Ghirri, P | 1 |
| Boldrini, A | 1 |
| Fink, B | 1 |
| Genazzani, AR | 1 |
| Coceani, F | 1 |
| Simoncini, T | 1 |
13 other studies available for n(g),n(g')-dimethyl-l-arginine and Fetal Growth Restriction
| Article | Year |
|---|---|
Maternal serum levels of asymmetric dimethylarginine in normal and preeclamptic pregnancies.
Topics: Adult; Arginine; Case-Control Studies; Cross-Sectional Studies; Female; Fetal Growth Retardation; Hu | 2020 |
The Effect and Mechanism of Asymmetric Dimethylarginine Regulating Trophoblastic Autophagy on Fetal Growth Restriction.
Topics: Adenine; Adult; Arginine; Autophagy; Beclin-1; Cell Line, Tumor; Female; Fetal Growth Retardation; H | 2021 |
Inverse correlation between maternal plasma asymmetric dimethylarginine (ADMA) and birthweight percentile in women with impaired placental perfusion: circulating ADMA as an NO-independent indicator of fetal growth restriction?
Topics: Adult; Arginine; Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Fetus; Gestational Age; | 2018 |
Amniotic Fluid Arginine from Gestational Weeks 13 to 15 Is a Predictor of Birth Weight, Length, and Head Circumference.
Topics: Adult; Amniotic Fluid; Arginine; Birth Weight; Dietary Supplements; Female; Fetal Growth Retardation | 2017 |
Arginine bioavailability and endothelin-1 system in the regulation of vascular function of umbilical vein endothelial cells from intrauterine growth restricted newborns.
Topics: Adult; Amidohydrolases; Arginase; Arginine; Case-Control Studies; Cell Proliferation; Cells, Culture | 2018 |
Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine.
Topics: Adolescent; Adult; Arginine; Case-Control Studies; Female; Fetal Growth Retardation; Humans; Infant, | 2014 |
The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction.
Topics: Adaptor Proteins, Signal Transducing; Adult; Arginine; Case-Control Studies; DNA-Binding Proteins; F | 2015 |
Increased Bronchial Hyperresponsiveness and Higher Asymmetric Dimethylarginine Levels after Fetal Growth Restriction.
Topics: Anthropometry; Arginine; Biomarkers; Bronchial Hyperreactivity; Child; Demography; Female; Fetal Gro | 2017 |
Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and plasma concentrations of asymmetric dimethylarginine in Turkish pre-eclamptic women without fetal growth retardation.
Topics: Adult; Analysis of Variance; Arginine; Chromatography, High Pressure Liquid; Female; Fetal Growth Re | 2010 |
Asymmetric dimethylarginine in normotensive pregnant women with isolated fetal intrauterine growth restriction: a comparison with preeclamptic women with and without intrauterine growth restriction.
Topics: Adult; Arginine; Biomarkers; Case-Control Studies; Female; Fetal Growth Retardation; Humans; Pre-Ecl | 2011 |
Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby.
Topics: Adult; Arginine; Blood Chemical Analysis; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; F | 2012 |
Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction.
Topics: Adaptation, Physiological; Adult; Arginine; Endothelial Cells; Endothelium, Vascular; Female; Fetal | 2012 |
Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction.
Topics: Adult; Arginine; Case-Control Studies; Female; Fetal Growth Retardation; Homocysteine; Humans; Pre-E | 2013 |